title: Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients with CKD?
authors.affiliation: University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. bernsj@uphs.upenn.edu
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Berns